US6586388B2
(en)
|
1988-04-08 |
2003-07-01 |
Stryker Corporation |
Method of using recombinant osteogenic protein to repair bone or cartilage defects
|
US7025959B1
(en)
|
1992-02-12 |
2006-04-11 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
MP121, a growth/differentiation factor of the TGF-β family
|
US7067637B1
(en)
|
1992-02-12 |
2006-06-27 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
Antibody or antibody fragments specific for a protein of the TGF-β family
|
US6120760A
(en)
|
1992-02-12 |
2000-09-19 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung |
Growth/differentiation factors of the TGF-β family
|
US6171584B1
(en)
|
1992-02-12 |
2001-01-09 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
Method of treatment with growth/differentiation factors of the TGF-β family
|
US5807713A
(en)
*
|
1992-02-12 |
1998-09-15 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung |
DNA encoding growth/differentiation factor
|
DE19525416A1
(de)
|
1995-07-12 |
1997-01-16 |
Bioph Biotech Entw Pharm Gmbh |
Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems
|
WO1994015949A1
(en)
*
|
1993-01-12 |
1994-07-21 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-5
|
CA2165776A1
(en)
*
|
1993-07-09 |
1995-01-19 |
Se-Jin Lee |
Growth differentiation factor-6
|
CA2165778A1
(en)
|
1993-07-09 |
1995-01-19 |
Se-Jin Lee |
Growth differentiation factor-7
|
IL110589A0
(en)
*
|
1993-08-10 |
1994-11-11 |
Bioph Biotech Entw Pharm Gmbh |
Growth/differentiation factor of the TGF- beta family
|
US6764994B1
(en)
|
1993-08-10 |
2004-07-20 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
Growth/differential factor of the TGF-B family
|
US6027919A
(en)
*
|
1993-12-07 |
2000-02-22 |
Genetics Institute, Inc. |
BMP-12 and BMP-13 proteins and DNA encoding them
|
ES2255059T3
(es)
*
|
1993-12-07 |
2006-06-16 |
Genetics Institute, Llc |
Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
|
IL114397A0
(en)
*
|
1994-07-01 |
1995-10-31 |
Bioph Biotech Entw Pharm Gmbh |
Growth/differentiation factor of the TGF-beta-family
|
PT770089E
(pt)
*
|
1994-07-13 |
2001-02-28 |
Univ Johns Hopkins Med |
Factor 12 de diferenciacao do crescimento
|
AU1120295A
(en)
|
1994-11-07 |
1996-05-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Cartilage-derived morphogenetic proteins
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
PL186518B1
(pl)
|
1995-04-19 |
2004-01-30 |
Bioph Biotech Entw Pharm Gmbh |
Białko, kompozycja farmaceutyczna i sposób wytwarzania białka
|
AP856A
(en)
*
|
1995-04-19 |
2000-07-12 |
Biopharm Gmbh |
A novel homodimer protein used in pharmaceutical preparation for treating cartlage and bone diseases.
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
PT831884E
(pt)
|
1995-06-05 |
2003-11-28 |
New York Society |
Uso de proteinas morfogeneticas do caso para cicatrizacao e reparacao da ligacao do tecido conjuntivo
|
US5902785A
(en)
*
|
1995-06-06 |
1999-05-11 |
Genetics Institute, Inc. |
Cartilage induction by bone morphogenetic proteins
|
ZA966489B
(en)
*
|
1995-08-03 |
1997-02-26 |
Bioph Biotech Entw Pharm Gmbh |
New protein human MP52 Arg.
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
JPH1080273A
(ja)
*
|
1996-05-13 |
1998-03-31 |
Hoechst Yakuhin Kogyo Kk |
Mp52に対するモノクローナル抗体
|
US5965403A
(en)
*
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
EA001579B1
(ru)
*
|
1997-01-30 |
2001-06-25 |
Хехст Марион Рассел Лтд. |
Лиофилизированная композиция морфогенетического фактора роста кости мр52 человека и способ её получения
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
WO1998054572A1
(en)
|
1997-05-30 |
1998-12-03 |
Creative Biomolecules, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6027917A
(en)
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
DE60205937T3
(de)
|
2001-11-19 |
2016-01-21 |
Scil Technology Gmbh |
Methode zur Herstellung einer homogen beschichtete Vorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaft
|
EP1539261B1
(en)
|
2002-09-10 |
2006-04-12 |
Scil Technology GmbH |
Metal implant coated under reduced oxygen concentration with osteoinductive protein
|
US7429378B2
(en)
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7344716B2
(en)
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7553827B2
(en)
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US8361467B2
(en)
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
EP2374471A1
(en)
|
2003-09-12 |
2011-10-12 |
Wyeth LLC |
Injectable hardenable calcium phosphate pastes for delivery of osteogenic proteins
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
US8372419B2
(en)
|
2004-03-10 |
2013-02-12 |
Scil Technology Gmbh |
Coated implants, their manufacturing and use thereof
|
EP1740609A2
(en)
|
2004-04-27 |
2007-01-10 |
Research Development Foundation |
Antagonism of tgf-beta superfamily receptor signaling
|
EP1763362B1
(en)
|
2004-05-25 |
2011-07-06 |
Stryker Corporation |
Use of op-1 for treating cartilage defects
|
US20060069008A1
(en)
|
2004-09-28 |
2006-03-30 |
Sanjay Mistry |
Treatment of neurological deficits in the striatum or substanta nigra pars compacta
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
ES2427993T3
(es)
|
2006-02-09 |
2013-11-05 |
Biomimetic Therapeutics, Llc |
Composiciones y métodos para el tratamiento de hueso
|
US20090298761A1
(en)
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
WO2008005427A2
(en)
|
2006-06-30 |
2008-01-10 |
Biomimetic Therapeutics, Inc. |
Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
CA2671925A1
(en)
|
2006-12-21 |
2008-07-10 |
Stryker Corporation |
Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
|
ES2402672T3
(es)
*
|
2007-01-25 |
2013-05-07 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
JP5323832B2
(ja)
|
2007-08-07 |
2013-10-23 |
アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー |
酸性水溶液中にgdf−5を含むタンパク質製剤
|
US8986696B2
(en)
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
EP2268302B1
(en)
|
2008-02-13 |
2014-04-09 |
Keith Hruska |
Bmp-7 for use in treating neointimal hyperplasia
|
US7947649B2
(en)
|
2008-04-14 |
2011-05-24 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered GDF-5 formulations
|
CA2735885C
(en)
|
2008-09-09 |
2018-08-28 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
|
EP2396025A2
(en)
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Peripheral administration of proteins including tgf-beta superfamily members for systemic treatment of disorders and disease
|
EP2396026A2
(en)
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
|
WO2010110974A1
(en)
|
2009-03-24 |
2010-09-30 |
Stryker Corporation |
Methods and compositions for tissue engineering
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
WO2011031856A1
(en)
|
2009-09-09 |
2011-03-17 |
Stryker Corporation |
Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
|
AU2010295509A1
(en)
|
2009-09-17 |
2012-04-19 |
Stryker Corporation |
Buffers for controlling the pH of bone morphogenetic proteins
|
JP2013514811A
(ja)
|
2009-12-22 |
2013-05-02 |
ストライカー コーポレイション |
免疫原性が抑制されたbmp−7変異体
|
BR112012020566B1
(pt)
|
2010-02-22 |
2021-09-21 |
Biomimetic Therapeutics, Llc |
Composição de fator de crescimento derivado de plaqueta
|
EP2598177B1
(en)
|
2010-07-30 |
2015-06-17 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH |
Drug delivery devices and growth factor formulations for accelerated wound healing
|
EP2537538A1
(en)
|
2011-06-22 |
2012-12-26 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH |
Bioresorbable Wound Dressing
|
WO2014012101A1
(en)
|
2012-07-13 |
2014-01-16 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
CN108430458B
(zh)
|
2015-10-26 |
2022-05-10 |
哈佛学院院长等 |
还原和氧化的多糖及其使用方法
|